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Abstract 
The current gold standard for screening and diagnosis of oral cancer and pre-
malignant lesions is the histopathological examination. However, it has its limitations, such 
as the subjectivity of the interpretation of morphological abnormalities in the tissue or cells, 
it is an invasive procedure and site selection for biopsy is not trivial. Although other methods 
are available for screening of these lesions, most are not sensitive enough and they are 
unable to make a definitive diagnosis. Raman spectroscopy, on the other hand, has been 
shown to be a potentially more accurate technique for the diagnosis of pathological changes 
in tissues and cells. Since it is known that biochemical changes precede morphological 
changes, Raman spectroscopy could be a potential screening technique for earlier 
diagnosis of cancer as it provides detailed information on the biological content of a sample 
through unique vibrations of its constituent molecules.  
In this thesis, the current tools for screening of potentially malignant oral lesions are 
discussed, as well as the potential of Raman spectroscopy as a tool for early diagnosis of 
these lesions. Analysis of Raman spectra of exfoliated oral cells indicated that lipids 
contribute strongly to the differentiation of cell samples from normal volunteers and those 
from patients with early-stage lesions. Since lipids are involved in the carcinogenesis 
process, they are explored as potential spectral markers. Following analysis of samples of 
individual lipidic samples, it was identified that sphingomyelin (SM) could be a potential 
spectral marker, although, to further validate this, it would necessary to collect samples only 
from patients that have never previously undergone any treatment, because SM, apart from 
being involved in lipidic deregulation in carcinogenesis, can also be changed as a result of 
cancer treatment such as chemotherapy (CT) and radiotherapy (RT). 3- sin- Phosphatidyl- 
L- serine (PS) also seems to play an important role in the carcinogenesis process, and 
indeed, PS was indicated in the analysis as a potential spectral marker.  
Cholesterol (CHO) is not implicated by the results, suggesting that there is no 
increase of CHO in the oral malignant cells, corroborating recent studies that CHO levels 
do not increase in cells during the development of cancer due to its greater demand from 
the cell by the carcinogenesis process or possibly, deregulation of lipidic metabolism. 
However, additional research is needed to confirm these effects. Overall, the results 
indicate that lipidic signatures may be viable spectral markers for disease, a concept which 
merits further investigation. 
Keywords: Oral cancer diagnosis, Raman spectroscopy, Biomarkers, Lipid biomarkers 
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Resumo 
O exame padrão para triagem e diagnóstico de câncer bucal e lesões pré-malignas 
é o exame histopatológico. No entanto, existem suas limitações, como a subjetividade da 
interpretação de anormalidades morfológicas em tecido ou células, ser um procedimento 
invasivo e a seleção do local para a biópsia não ser trivial. Embora outros métodos estejam 
disponíveis para o rastreamento dessas lesões, a maioria não é sensível o suficiente e são 
incapazes de fazer um diagnóstico definitivo. A espectroscopia Raman, por outro lado, tem 
se mostrado um instrumento potencial e mais preciso para o diagnóstico de alterações 
patológicas nos tecidos e células. Como é sabido que as alterações bioquímicas precedem 
as alterações morfológicas, a espectroscopia Raman pode ser uma técnica potencial de 
triagem para diagnóstico precoce de câncer, pois fornece informações detalhadas sobre o 
conteúdo biológico de uma amostra através de vibrações únicas de suas moléculas 
constituintes.  
Nesta tese, são discutidas as ferramentas atuais para o rastreamento de lesões 
orais potencialmente malignas, bem como o potencial da espectroscopia Raman como uma 
ferramenta para o diagnóstico precoce dessas lesões. A análise dos espectros Raman de 
células esfoliadas orais indicou que os lipídios contribuem fortemente para a diferenciação 
de amostras celulares de voluntários normais e de pacientes com lesões em estágios 
precoces. Como os lipídios estão envolvidos no processo de carcinogénico, eles são 
explorados como potenciais marcadores espectrais. Após análise de amostras de amostras 
lipídicas individuais, identificou-se que a esfingomielina (SM) poderia ser um potencial 
marcador espectral, embora, para validar isso, seria necessário coletar amostras apenas 
de pacientes que nunca haviam passado por nenhum tratamento, porque a SM, além de 
estar envolvida na desregulação lipídica na carcinogénese, também pode ser alterada 
como resultado do tratamento do câncer, como quimioterapia (CT) e radioterapia (RT). A 
3-sin-Fosfatidil-L-serina (PS) também parece desempenhar um papel importante no 
processo de carcinogénese e, de facto, a PS foi indicada na análise como um potencial 
marcador espectral.  
O colesterol (CHO) não é implicado pelos resultados, sugerindo que não há 
aumento de CHO nas células malignas orais, corroborando estudos recentes de que os 
níveis de CHO não aumentam nas células durante o desenvolvimento do câncer devido à 
maior demanda da célula pelo processo de carcinogénese ou possivelmente, pela 
desregulação do metabolismo lipídico.  
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No entanto, pesquisas adicionais são necessárias para confirmar esses efeitos. No 
geral, os resultados indicam que as assinaturas lipídicas podem ser marcadores espectrais 
viáveis para doenças, um conceito que merece mais investigação. 
Palavras-Chave: Diagnóstico de cancro oral, Espectroscopia Raman, 
Biomarcadores, Lipídios como biomarcadores 
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I INTRODUCTION 
Cancer of the oral cavity and the pharynx collectively contribute to substantial morbidity and 
mortality worldwide (Ferlay et al., 2015). Globally, pharyngeal, oral cavity, and lip cancers 
are responsible for around 529,500 incident cases and 292,300 deaths in 2012, 
representing about 3.8% of all cancer cases and 3.6% of cancer deaths (Shield et al, 2017).  
About 6% of oral cancers occur in people under the age of 45. There is an increased 
incidence in the mortality rate of oral and oropharyngeal cancer in young adults in European 
Union and parts of the United States (Warnakulasuriya, 2009).  
The observed trends in incidence and mortality among men and women are closely 
correlated with the patterns and trends in tobacco and alcohol use (Sankaranarayanan et 
al., 2015). In the last decade, there has been a growing trend of oral cancer in the 
Portuguese population, in both sexes and especially in females (Albuquerque et al., 2012). 
Surgery and radiotherapy are standard treatments for precancerous and cancerous lesions 
of the oral mucosa, but these treatment modalities are associated with complications 
(Ribeiro et al., 2010) and may leave severe sequelae (Warnakulasuriya, 2009; Vissink, 
2003) that decrease the quality of life of the patient, resulting in: difficulty in swallowing and 
speech; hyposalivation; radiation-induced dental caries; dysgeusia; disturbances in bone 
remodelling; trismus; mutilations resulting from surgical treatment; depression (due to 
mutilation) and nutritional deficiency (as a consequence of the overall picture of sequels) 
(Warnakulasuriya et al., 2007). Furthermore, recurrence and secondary tumours influence 
survival rates (Bissinger et al., 2017).   
Carcinoma is considered an injury with great chances of prevention, considering that the 
major risk factors are smoking and associated alcohol abuse (Warnakulasuriya et al., 2009). 
According to the World Health Organisation (WHO), European Region has the highest 
current percentage of smokers among adults over 15 years of age, among all WHO regions. 
Approximately 41% of men and 22% of women currently smoke tobacco products. In 
contrast, in the world there are 36% of men and 8% of women (WHO, 2009). In addition, 
the population in Europe are the largest consumers of alcohol in the world (WHO, 2013). 
Oral squamous cell carcinoma (OSCC) is the most frequent type of cancer in the head and 
neck region and it is associated to the poor prognosis because only around 50% of the 
patients survive 5 years after diagnosis and 145,000 deaths per year are registered 
worldwide (Upchurch et al., 2018).  
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Oral cancers mostly develop from potentially malignant lesions (precancerous) (Hadzic et 
al., 2017). Although, the oral cavity is accessible for visual examination, oral cancer is 
generally diagnosed at a late stage as a result of a lack of awareness of the risk factors and 
symptoms among the public in addition to a lack of prevention and early detection by oral 
physicians and healthcare providers (Kaur et al., 2018).   
The histopathological examination of a sample is based on the analysis of morphological 
characteristics of the tissue and does not provide information about biochemical changes 
that occur in the carcinogenic process (Mehrotra et al., 2006). Further, despite this 
technique being the gold standard for diagnosis, it is based on subjective analysis and 
depends on the individual experience of the pathologist, the size depth and quality of the 
specimen, fixation and freezing technique (Liu et al., 2016). 
The early diagnosis of oral cancer is fundamental to prevent future unfavourable conditions 
for patients. Although there are already some diagnostic exams performed at the 
ambulatory clinic and in the pathology laboratory that detect these lesions, it is important to 
search for new methods that can help the earlier diagnosis of the disease in an increasingly 
accurate way. 
In this dissertation, the most common auxiliary diagnostic methods will be discussed, and 
the development of a new potential diagnostic screening method based on Raman 
spectroscopy will be explored. 
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II LITERATURE REVIEW  
1. Oral Squamous Cell Carcinoma  
Approximately 94% of all oral malignancies are squamous cell carcinomas. As for many 
other carcinomas, the risk of oral cancer increases with age, especially for men (Neville et 
al, 2009).  
OSCC is an aggressive malignancy that can result from malignant conversion of oral 
leukoplakia (OL) or occur de novo. Although OSCC can result from a pre-existing area 
of leukoplakia, only about 15% arise from a pre-existing lesion (Bewley and Farwell, 2017). 
1.1. Main risk factors 
The cause of OSCC is multifactorial (Neville et al, 2009), although, identifiable etiological 
factors are predominantly exogenous factors such as tobacco, areca nut, alcohol, poor diet, 
viral infections, and pollution (Sankaranarayanan et al., 2015). 
1.1.1. Tobacco 
Tobacco is the most important risk factor for mouth cancer and potentially malignant lesions. 
Smoking or chewing tobacco habits, betel-quid chewing with or without tobacco, are 
associated with the development of these lesions (Reichart, 2001; Sankaranarayanan et 
al., 2015). Approximately 80% of patients with OSCC have a history of smoking or tobacco 
use (Bewley and Farwell, 2017).  
1.1.2. Alcohol 
Alcohol has been associated as a risk factor for the development of OSCC. Drinking 
alcoholic beverages increase the risk of oral cancer by up to six times and is an independent 
risk factor (IARC, 2010). Studies have been reported a synergistic effect of alcohol and 
tobacco, heavy users of both having more than 100 times greater risk of OSCC (Bewley 
and Farwell, 2017).   
1.1.3. HPV 
The Human Papilloma Virus (HPV) has been shown to play a role in the pathogenesis of 
head and neck squamous cell carcinomas and oropharyngeal squamous cell carcinoma 
(for example, pharynx, larynx and oral cavity) (Candotto et al., 2017). 
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1.1.4. Poor Nutrition 
High consumption of fruits and vegetables is associated with a reduction of 40% to 50% in 
the risk of oral cancer (Sankaranarayanan et al., 2015). However, chemoprevention studies 
have not still established a preventive effect of retinoid and carotenoid dietary supplements 
(Sankaranarayanan et al., 2015). 
1.2. Management 
Initially, a biopsy of any lesion suspected of oral cancer is essential to establish a diagnosis. 
After the clinical evaluation and suspect lesion confirmed, it is necessary to do a computed 
tomography (ct) or magnetic resonance imaging (MRI) to detect the primary tumour, 
evaluate cervical lymph nodes, possible metastatic in the neck and existence of distant 
metastatic regions (Bewley and Farwell, 2017). 
Normally, the primary treatment modality for most OSCCs is surgical resection. The main 
goal of surgical resection is achieving negative margins to avoid the recurrence. Adjuvant 
therapy consists of radiotherapy (RT) or/and chemotherapy (CT) (Bewley and Farwell, 
2017). 
1.2.1. Chemopreventive Agents 
The main goal of chemoprevention is to reduce the cancer incidence by prescribing 
pharmacological agents and dietary supplementation with vitamins, minerals, trace 
elements, bioactive substances and so on (Anderson et al., 2001). 
Vitamin A and carotenoids (in particular beta-carotene), vitamin C and selenium have been 
associated as protectors against most epithelial cancers and also precursor lesions. Their 
potential effect is related to their antioxidant activities. Antioxidants reduce free radicals 
which may cause DNA mutations and lipid peroxidation changes in the cell membranes 
(Amarasinghe et al., 2013). 
Other functions of the antioxidants would be modulation of carcinogenic metabolism, 
maintenance of appropriate cell differentiation, inhibition of cell proliferation and expression 
of the oncogene, maintenance of immune function and inhibition of the formation of 
endogenous carcinogens (Amarasinghe et al., 2013). 
Some of the retinoids available for use in the clinic are tretinoin (all-transrestonic acid), 
isotretinoin (13-cis-retinoic acids) and etretinate (retinoic ethyl ester) (Anderson et al., 
2001). 
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Unfortunately, however, toxicity has been reported for use of several chemopreventive 
agents. Among the symptoms, there are headache, alopecia, carotenodermia, facial 
erythema, peeling, conjunctivitis, photophobia and liver damage (Warnakulasuriy, 2009). 
Furthermore, a serious drawback of chemoprevention is relapse of the lesion after 
discontinuation of treatment (Gomes and Gomez, 2013).  
2. Potentially Malignant Oral Disorders and Dysplasia 
Most oral carcinoma has a long preclinical phase called potentially malignant lesions (PML) 
(Sankaranarayanan et al., 2015). PML are lesions in the oral mucosa which are an 
increased risk for malignant transformation compared to healthy mucosa. The most 
common PML are leukoplakia, erythroplakia, oral lichen planus, and actinic cheilitis, being 
OL one of the most common precancerous lesions of OSCC (Dietrich et al., 2004; Hadzic 
et al., 2017). 
The approximated yearly frequency of malignant transformation of oral precancerous 
lesions ranges from 0.13% to 2.2% (Sankaranarayanan et al., 2015). The clinical 
importance of OL is due to its identity as a precursor to OSCC (Bewley and Farwell, 2017).  
2.1. Clinical Presentation of Leukoplakia 
The estimated prevalence of leukoplakia in the world is approximately 2% (Petti, 2003). Its 
risk of neoplastic transformation is around 3% to 13,8% and when there is presence of 
dysplasia in the lesion, the risk increases to 30% to 40% (Lohe et al., 2009; Kawczyk-Krupka 
et al., 2012). 
The term leukoplakia is used to describe white plaques of questionable risk, having 
discounted other known lesions that are not at increased risk for cancer (Warnakulasuriya 
et al., 2007). 
WHO (2005) defines leukoplakia as "a plaque or white spot that cannot be clinically or 
pathologically characterised as any other disease." Therefore, this nomenclature is 
considered merely clinical because the lesion has no specific histopathological alteration. 
(Neville et al., 2009). The lesion has a standard variable of behaviour that may or may not 
have epithelial dysplasia but has a tendency for malignant transformation (Warnakulasuriya 
et al., 2007). 
A provisory diagnosis of leukoplakia is made when a predominantly white lesion on clinical 
examination is not clearly diagnosed as any other oral mucosal disease or disorder. A 
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definitive diagnosis is already made when any etiological cause, except tobacco and the 
use of areca nut, has been excluded and histologically no other specific disorder has been 
confirmed (Warnakulasuriya et al., 2007).  
A schematic diagram proposed by Warnakulasuruya (2007) to aid in the diagnosis of OL is 
shown in FIGURE 1 below. 
 
Figure 1.  Schematic representation of the stages in the diagnosis of OL (Adapted from 
Warnakulasuriya et al., 2007). 
According to Warnakulasuriya et al. (2007) leukoplakia lesions can be classified as 
homogeneous and nonhomogeneous. Homogeneous lesions are smooth and thin and have 
a shallow keratin surface. Their probability for malignant transformation is relatively low. On 
the other hand, non-homogeneous lesions imply a high risk of malignant transformation. 
These lesions may be: speckled, nodular and verrucous. 
The location of OL has a significant correlation with the frequency of findings of dysplastic 
or malignant changes in biopsy (Neville and Day, 2002). Lesions in the tongue, vermilion of 
the lips and buccal floor add up to 90% of those with dysplasia or carcinoma (Neville et al., 
2009). 
The most recognised factors that there is an increased risk of malignant transformation to 
squamous cell carcinoma are: female gender, leukoplakia in non-smokers, duration of 
leukoplakia, location on tongue and / or floor of the mouth, size larger than 200mm², 
nonhomogeneous lesions, presence of epithelial dysplasia and DNA aneuploidy (Van der 
Waal, 2009). 
White Patch
Exclusion of other known 
conditions / disorders / 
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and examination
Provisional clinical 
diagnosis of Leukoplakia
BIOPSY
Confirmation of other 
known disorders
Review diagnosis for other 
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2.2. Histopathological Aspects 
Histologically, OL is characterised by a thick layer of keratin in the surface epithelium, with 
or without acanthosis (thickening of the spinous layer). Chronic inflammation cells are 
usually seen within the underlying connective tissue. The keratin layer may consist of 
parakeratin (the epithelial nuclei are retained in the keratin layer and there is no layer of 
granular cells), orthokeratin (nuclei are absent in the keratin layer and there is a layer of 
granular cells) or a combination of both (Neville et al., 2009). 
Dysplasia is considered an alteration of the stratified squamous epithelium, accompanied 
by the presence of cellular atypia and loss of maturation and stratification (Reibel, 2003). 
In 5% to 25% of the OL cases, epithelial dysplasia is present. When present, such dysplastic 
changes typically start at the basal and parabasal portions of the epithelium. The 
histopathological changes of dysplastic epithelial cells are similar to those observed in 
squamous cell carcinoma (Neville et al., 2009).  
Oral epithelial dysplasia can be considered as morphological phenotypes of different 
progression stages from a normal tissue to a malignant tissue. The WHO classified 
epithelial dysplasia in 2003 as mild, moderate and severe hyperplasia or carcinoma in situ. 
This classification is made according to the presence of cellular atypia severity and cell 
architecture characteristics based on dysplastic layer thickness compared to total epithelial 
height (MacDonald, 2003). The frequency of presenting epithelial dysplasia, carcinoma in 
situ, verrucous carcinoma or invasive squamous cell carcinoma in OL is 8.6% to 60% (Woo 
et al., 2014).  
In 2005, WHO considered architectural features and cytological changes to determine 
degree of dysplasia. Among them are: 
 Architectural criteria: irregular stratified epithelium; loss of basal cells 
polarity; epithelial crests in the form of gout; increased number of mitoses; 
abnormal surface mitosis; premature keratinisation in individual cells and 
keratin follicles within the epithelial ridges. 
 Cytological criteria: abnormal variation of nucleus size; abnormal variation of 
core shape; abnormal variation of cell size; nucleus / cytoplasm ratio; 
increased core size; atypical mitoses; increase in number and size of the 
nucleolus and hyperchromatism. 
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One of the objectives of the WHO histopathological grading system for oral epithelial 
dysplasia (2005) is to assist in the prediction of malignant transformation of the lesion. 
However, there are currently no objective methods for the classification of dysplasia that is 
possible to reproduce results (Sperandio et al., 2002). Graduation is hampered by the 
arbitrary division into distinct categories a continuous and progressive process that does 
not have well-defined boundaries, making it artificial (Bosman, 2001). 
2.3. Differential Diagnosis 
OL clinically resembles many oral lesions. Therefore, it is important to establish the clinical 
differential diagnosis so that a provisional diagnosis can be reached (Warnakulasuriya et 
al., 2007). 
A provisional diagnosis of OL is made when the lesion in question is predominantly white 
and, by clinical examination, it cannot be diagnosed as any other oral mucosal disorder. A 
biopsy is mandatory for a definitive diagnosis, and this is performed when histologically is 
not confirmed as any other disorder (Warnakulasuriya et al., 2007). 
There are many white oral lesions that should be considered and excluded in order to 
conclude a provisional OL diagnosis. Among them are those described in TABLE 1 
(Warnakulasuriya et al., 2007; Van der Waal, 2009): 
Table 1. Descriptions of important lesions in the differential diagnosis (Adapted from 
Warnakulasuriya et al., 2007; Van der Waal, 2009). 
White sponge nevus Observed early in life, family history, large areas involved, 
genital mucosa may be affected. 
Frictional keratosis A history of trauma, especially along the occlusal plane, there 
is an apparent etiological cause, in most cases reversible with 
the elimination of the cause. 
Morsicatio buccarum Known bite of lips, presence of irregular whitish flakes. 
Chemical injury Known history, lesion site corresponds to chemical injury, 
painful symptomatology, rapid resolution. 
Acute 
pseudomembranous 
candidiasis 
The membrane can be removed by scraping leaving an 
erythematous surface. 
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Leukoedema Bilateral buccal mucosa, can be made to disappear in the 
stretch, related to black ethnicity. 
Lichen planus (plaque 
type) 
Other forms of lichen planus (reticular) found in association. 
Lichenoid reaction History of drugs such as near a restoration of amalgam. 
Discoid lupus 
erythematosus 
Circumscribed lesion with central erythema, white lines 
radiating. 
Skin graft Known history. 
Hairy leukoplakia Bilateral keratosis on the tongue. 
Nicotine stomatitis 
(nicotine palatine, 
smoker's palate) 
History of smoking, presence of greyish-white palate. 
Aspirin burn History of local application of aspirin tablets. 
Hyperplastic 
candidiasis 
There is no consensus in the literature as to whether oral 
hyperplastic candidiasis is recognised, so some are referred 
to as lesion of candida associated with leukoplakia. 
Linea alba Clinical aspect located in the line of occlusion of the mucosa 
of the cheek. 
Secondary syphilis Clinical appearance and presence of T. pallidum in serology. 
Papilloma Clinical aspect and histopathological examination. 
Snuff-induced injury Clinical appearance, where snuff was placed. 
For a differential diagnosis of OL in histopathological examinations, it must be considered 
that the reactive, regenerative or repaired squamous epithelium due to trauma, 
inflammation, irradiation or ulceration may manifest with atypical cytology or architectural 
disorder. Nutritional deficiencies like iron, folic acid and vitamin B12 may also mimic 
dysplasia (Warnakulasuriya et al., 2008). 
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Therefore, clinical history is important and suggestive morphological changes that stimulate 
events such as ulceration, inflammation, haemorrhage, nuclear fibroblast enlargement and 
/ or radiation-induced endothelium and hyperchromatism may be present (Warnakulasuriya 
et al., 2008). 
2.4. Clinical Aspect vs Degree of Cell Differentiation 
The histological grade of epithelial dysplasia is what determines which OL treatment will be 
performed. However, the degree of dysplasia does not always determine the potential risk 
of malignancy. Thus, clinical specificity is essential to complement the prognosis and 
therapeutic decisions (Warnakulasuriya, 2001). 
Some clinical features of potentially malignant lesions aid in risk assessment and aid in 
correlation with microscopic analyses (Warnakulasuriya, 2001). 
The clinical appearance of OL may indicate some correlation with the probability of 
appearance of dysplasia or malignant characteristics. In general, the thicker the leukoplakia, 
the greater the chance of finding dysplastic changes upon histopathological examination. 
Therefore, a verrucous leukoplakia is more likely to present with dysplasia compared to a 
thick homogeneous leukoplakia, and this, in turn, is more likely to exhibit this type of 
alteration than a thin homogeneous leukoplakia (Neville and Day, 2002). 
However, regardless of its clinical aspect, an in-depth investigation of the lesion must be 
carried out, since even apparently harmless lesions may have significant dysplasia or even 
carcinoma (Neville and Day, 2002). 
2.5. Ancillary Methods of Diagnostics 
A variety of diagnostic aids and adjuvant techniques are available to assist in screening 
patients with occult cancerous changes or to assess the biological potential of mucosal 
lesions (Lingen et al., 2008). 
A simple, safe diagnostic procedure is necessary, with the possibility of lesion early 
detection. In the literature some important ancillary methodologies are found. Among them 
are: exfoliative cytology, vital staining, light-based detection systems, optical spectroscopy 
and oral cancer biomarkers.  
2.5.1. Exfoliative Cytology 
Oral biopsy represents the gold standard to determine the nature of the mucosal lesion and 
complete a diagnosis. However, exfoliative cytology has been used for the evaluation of 
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oral epithelial cells with the advantage of being less invasive and not requiring local 
anaesthesia compared to biopsy (Epstein et al., 2002). 
Oral cells can be obtained by different physical scraping systems from the surface of the 
mucosa, by washing the oral cavity or from a saliva sample (Mehrotra et al., 2006). 
The cytological study of oral cavity cells is simple, rapid, non-aggressive and relatively 
painless. Therefore, it is considered a well-accepted technique by patients and suitable for 
the routine application of screening programs in the population, both for the early analysis 
of suspected lesions and for pre and post-treatment monitoring of confirmed malignant 
lesions (Mehrotra et al., 2006). 
Exfoliative cytology was introduced as a potential oral cancer detection protocol in 1999 
(Lingen et al., 2008). It was designed to be used in cases where the level of suspected 
carcinoma is low based on clinical characteristics. However, a biopsy should be performed 
if the test result is atypical or positive, as cytology does not provide a definitive diagnosis 
(Lingen et al., 2008). 
This technique, despite its limitations, allows patients with multiple suspected lesions in the 
oral cavity to benefit from not having to undergo several biopsies (Lingen et al., 2008). 
However, exfoliative cytology associated with other sophisticated diagnostic techniques, 
such as cytomorphometry, DNA cytometry and molecular analyses, have demonstrated 
efficient results (Mehrotra et al., 2006). Therefore, it is becoming increasingly important in 
the early diagnosis of oral cancers (Mehrotra et al., 2006). 
2.5.2. Vital Staining 
2.5.2.1. Toluidine Blue Staining 
Vital staining is the staining of living tissue cells. There are two techniques of vital staining, 
called intravital fixation in the living organism (in vivo) and supravital staining outside the 
body, usually applied in individual cell preparation (Culling et al., 1985). Toluidine Blue (TB) 
is an intravital fixation for nucleic acids and abnormal tissues (Parlatescu et al., 2014). 
TB, scientifically called tolonium chloride, is a member of the thiazine group of 
metachromatic dyes. The chemical compound consists of a double zinc chloride salt of the 
amino dimethyl amino toluenethiazinium chloride group, as schematised in FIGURE 2, 
which is partially soluble in water and alcohol and can be used intravenously or as a surface 
dye (Missmann et al., 2006). 
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Figure 2.  TB structure. 
The TB technique was first applied in 1963 in vivo by Reichart for cervical carcinoma in situ 
(Siddiqui et al., 2006). Since then, this dye has been used as an aid to the identification of 
abnormalities in the cervical mucosa as well as in the mucosa of the oral cavity (Lingen et 
al., 2008). 
In the oral cavity, the method is used to guide the selection of the biopsy site (Parlatescu et 
al., 2014). This method has been valued by surgeons as a useful way of demarcating lesion 
extension before excision (Lingen et al., 2008). 
TB may be used as 1% to 2% as oral rinse, as a local application in aqueous form, as a 
weak acid solution or in indefinite formulation (Warnakulasuriya and Johnson, 1996). 
A proposal for the explanation of the selectivity of TB staining may be that the dye has a 
higher affinity for acidic structures. Because dysplastic and neoplastic cells contain nucleic 
acids in greater amounts than normal tissues, these cells become more stained (Gandolfo 
et al., 2006). 
Sensitivity is the ability of a test to detect disease among carriers. Specificity, however, is 
the ability of a test to indicate a negative result when there is no disease (Atman and Blan, 
1994). 
Sensitivity studies performed by Onofre et al. (2001) demonstrated that TB has a high 
sensitivity in the detection of malignant oral lesions. The values obtained ranged from 84% 
to 100% and there were no false-negative results in lesions with histological diagnosis of 
carcinoma. On the other hand, there have been studies in which false-negative results 
ranged from 0.9% to 5.5% of the total sample and in others there was a 58% false-negative 
percentage for epithelial dysplasia. This discrepancy should certainly be due to the authors 
considering coloration only in sites with dotted or dark coloration as positive and areas that 
were poorly stained as negative (Onofre et al., 2001). 
In the same study by Onofre et al. (2001), it was observed that 100% of the false-positive 
results were lesions that presented ulcerations and erythema. Thus, the specificity of 44% 
increased to 65% after the removal of irritation and inflammatory factors and subsequent 
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application of TB. The probability of non-pigmented regions of TB not having epithelial 
dysplasia or atypical cells was 88.9% and in cases of carcinoma the probability was 100%, 
since there were no cases of false negative in these lesions. 
However, despite the positive results shown, TB used topically affects only the superficial 
cellular layers (from 3 to 4 cell layers approximately). Thus, initial malignant lesions, which 
are coated with intact epithelium, are not stained (Wysocki, 1999). Therefore, it is 
recommended that any lesion stained with TB should be considered a biopsy candidate 
(Zhang et al., 2005).  
2.5.3. Light-Based Detection Systems 
2.5.3.1. ViziLite Plus and MicroLux DL 
Chemiluminescence involves the emission of light from a chemical reaction between 
acetylsalicylic acid and hydrogen peroxide inside a capsule light stick. This reaction emits 
blue / white light (430-580nm) which can be used to monitor the reflection properties of 
tissues that present cellular alterations such as a higher nuclear / cytoplasmic ratio (Nagi et 
al., 2016) 
The method consists of prior application to the mucosa of an agent that promotes mild 
dehydration of the cellular cytoplasm such as acetic acid solution (acetic acid pre-rise). 
White lesions are then clearly evident because the acid solution promotes changes in the 
refractive pattern of the light. This occurs only where there is cellular atypia, that is, change 
in relation to nucleus / cytoplasm ratio (nucleus proportionally larger than the cytoplasm) in 
relation to the normal cell (Farah and McCullough, 2007). 
In this way, healthy tissue absorbs the light and as result appears darker and on the other 
hand, the suspected lesions are shown to be whiter and more evident, which favours the 
evaluation and delimitation of its borders, as well as the selection of the best biopsy site 
(Farah and McCullough, 2007). 
This method has been used for many years as a coadjutant in cervical mucosa examination 
and recently was adapted for use in the oral cavity with the aim of improving the 
identification of oral mucosa abnormalities (Lingen et al., 2008). 
Chemiluminescence for use in the oral cavity is marketed under the name ViziLite Plus and 
MicroLux DL. According to Lingen et al. (2008), in both systems the patient must rinse the 
buccal cavity prior to the examination with a solution of 1% acetic acid in order to remove 
the debris present on the surface and glycoprotein layer for enhanced penetration and 
21 
reflection of light. Thus, there is a promotion of increased visibility of epithelial cell nuclei, 
possibly due to mild cellular dehydration.  
Subsequently, a direct visual examination is done using the blue-white light source. The 
difference between the two is that ViziLite Plus uses a disposable chemiluminescent light 
package, while the MicroLux offers a reusable light source that is battery-operated. In 
addition, ViziLite Plus also provides a TB solution for labelling an acetowhite lesion for 
biopsy after removing light (Lingen et al., 2008). 
By using the blue-white light source on the tissue, the normal epithelium, therefore, shows 
as slightly bluish, while the abnormal epithelium shows with white colouration (Lingen et al., 
2008). 
2.5.3.2. Autofluorescence (VELscope®) 
The autofluorescence of tissue and its potential use in cancer detection was described first 
in 1924 for proteins. It is a phenomenon where by a light source is used to excite 
endogenous fluorophores such as certain amino acids, metabolic products, and structural 
proteins (Nagi et al., 2016).  
The most relevant fluorophores in the oral mucosa are nicotinamide adenine dinucleotide 
(NADH) and flavin adenine dinucleotide (FAD) in the epithelium and cross-links of the 
collagen in the stroma (Liu et al., 2016). Fluorophores absorb photons from the exogenous 
light source and emit low energy photons that exhibit fluorescence clinically (Paderni et al., 
2011). 
The VELscope® system is a handheld device developed by LED Diagnostic Medical 
("LEDMD") in association with scientists from the British Columbia Cancer Agency (BCCA). 
It detects the loss of visible or non-visible fluorescence of high-risk oral lesions by applying 
direct fluorescence. The loss of fluorescence reflects a complex mixture of changes in the 
intrinsic tissue distribution of fluorophores (Trullenque-Eriksson et al., 2009). 
VELscope® is a reusable light source that emits a cone of light in the blue spectrum (400-
460nm) into the oral cavity, causing fluorophores in the oral tissue to be excited and 
fluoresce. Fluorescence of the oral mucosa can be visualised directly through a narrow 
band filter embedded within the handpiece (McNamara et al., 2012).  
The normal mucosa emits a pale green autofluorescence when viewed through the 
selective filter (narrow band). In contrast, abnormal or suspect tissues exhibit decreased 
levels of normal autofluorescence and appear dark in relation to surrounding healthy tissues 
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(Lane et al., 2006). It happens due to changes in tissue architecture and concentrations of 
fluorophores which cause different absorption and scattering properties light (Liu et al., 
2016). 
Preliminary studies confirm that VELscope® can assist in the detection of hidden lesions in 
the oral mucosa, as well as in the identification of the extent of epithelial dysplasia 
(McNamara et al., 2012). However, it also can show other common conditions in oral 
mucosa such as pigmentation, ulceration, irritation and gingivitis among others (Liu et al., 
2016).   
2.5.4. Vibrational Spectroscopy 
Spectroscopy studies the interaction of radiation the electromagnetic field with the matter, 
one of its main objectives being the determination of the energy levels of atoms or molecules 
(Singh, et al., 2016). 
Optical spectroscopy methods such as Fourier Transform Infrared (FTIR) and Raman 
Spectroscopy, have been reported as potential tools to detect neoplastic changes. One of 
the most important features of these new tools is that they provide information about the 
biochemical composition of the changes that occur in the tissues (Krishna et al., 2006). 
Vibrational spectroscopy (VS) is used to study a variety of samples allowing qualitative and 
quantitative analysis. Samples may be analysed in bulk or in microscopic amounts in 
different temperatures and physical states such as gases, liquids, latexes, powders, films, 
fibres, as a surface or embedded layer (Larkin, 2011). 
2.5.4.1. Fourier-Transform Infrared Spectroscopy (FTIR) 
The fingerprint region of the FTIR spectrum has been widely employed to highlight the 
characteristic differences between tissue pathologies, based on changes in both frequency 
and intensity ratio of spectral bands (Mehrotra et al., 2007). The technique allows to study 
the state of the chemical bonds and the relative concentration of lipids, proteins, 
carbohydrates and phosphorylated molecules (Mehrotra et al., 2007).  
Spectral differences have been characterised and some markers have been established to 
identify disease in tissue sample (Mehrotra et al., 2007). FTIR is a sensitive tool for revealing 
changes in the structural and biochemical properties that occur in healthy and abnormal 
tissues (Diem et al., 2016). Thus, the use of FTIR for the detection and monitoring of 
alterations related to the malignant transformation of a tissue has been reported (Mehrotra 
et al., 2007; Singh et al., 2015; Pilling et al., 2017). 
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Infrared (IR) spectroscopy takes advantage of absorption phenomena. In this case, the 
focused photon excites a ground state molecule to one of the higher vibrational states of 
the molecule. The incident photons are only absorbed if their frequency corresponds exactly 
to the frequency of a specific molecular vibration in the material (FIGURE 3). Thus, it is 
possible to determine the spectrum (IR spectrum) of the molecule by measuring the 
intensity of light not absorbed at different frequencies (Mazzei, 2014).  
 
Figure 3.  Photons with energies hω1, hω2, and hω3 hit a two-level system. Only hω2 has the same 
energy as the difference between the two vibrational states, and it is therefore absorbed. 
Afterwards, the resulting IR absorbance spectrum (Adapted from Mazzei, 2014). 
 
IR causes vibrations of molecular bonds within the irradiated sample. The incident 
wavelength absorbed depends on the atoms involved and the strength of intermolecular 
interactions.  
In order for molecules irradiated by IR to absorb this radiation, the vibrations in the 
molecules must induce a change in the dipole moment of the molecular (Clemens et al., 
2014).  
In this way, for IR absorption, a molecular oscillates can only be observed if the dipole 
moment modulates. This means that diatomic homonuclear molecules do not give rise to 
bands in the IR spectra, since they do not have a dipole moment:  
𝜕𝜇
𝜕𝑄
 ≠ 0 
where μ is molecular dipole moment, and Q is normal coordinate of vibration (Mazzei, 
2014). 
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IR spectroscopy is, label free, and therefore cost-effective tool (no need for expensive 
reagents), simple to operate and requires simple sample preparation (Clemens et al., 2014). 
2.5.4.2. Raman Spectroscopy  
Raman spectroscopy is possibly among the techniques that will dominate medical biological 
research in the next decade (Magdalena et al., 2016). 
Similar to IR absorption spectroscopy, it measures the vibrational spectrum of constituent 
biomolecules and thus presents a biochemical fingerprint of the sample. This technique has 
the advantage of being simple and versatile because it does not require special sample 
preparation and can be performed in the visible or near infrared region of the spectrum, and 
thus can be easily adapted for in situ / in vivo or endoscopic measurements (Magdalena et 
al., 2016). Raman spectroscopy is discussed in more detail in Section 3.  
2.5.5. Oral Cancer Biomarkers 
Biomarkers are molecules found in tissues or in body fluids that serve as signals for normal 
or abnormal processes in the body (Sharma and Kanwar, 2017). 
They are predominantly proteins (enzyme or receptor), nucleic acids (microRNA and 
methylated DNA), glycoprotein, carbohydrate that change in pathological processes 
(Sharma and Kanwar, 2017). 
Biomarkers are used for cancer screening, diagnosis, monitoring, and recurrence. However, 
due to its heterogenicity, to establish a biomarker, it is important to have knowledge of the 
pathogenic mechanism that leads to carcinogenesis for each specific tumour (Sharma and 
Kanwar, 2017). 
Several molecular markers are being studied and have provided a new understanding of 
the pathogenesis in OSCC (Bissinger et al., 2017).  
Salivary biomarkers might be a non-invasive, speedy adjuvant tool for revealing a malignant 
transformation, such as miRNA-184 and interleukin-6 (IL-6) as reported previously (Liu et 
al., 2016).  
In addition, other potential biomarkers in oral cancer have been identified. Cyclin D1, 
Epidermal growth factor receptor (EGFR), P53 mutation, are associated with increased risk 
of locoregional recurrence and metastasis in OSCC (Gupta et al., 2016).  
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Cyclin D1 is a protein required for the progression of the cell cycle from G1 to S phase. 
Dysregulation of cyclin D1 expression or function contributes to the loss of normal cell cycle 
control during tumorigenesis. 
Cyclin D1 is a protein required for the progression from G1-phase to the S-phase of cellular 
cycle. Deregulation of cyclin D1 is involved in the loss of normal cell cycle control during 
cancer development. Overexpression of cyclin D1 has been linked to recurrence and 
reduced overall survival in oral cancer patients (Huang et al., 2012).    
EGFR and P53 gene are proteins that have been associated with tumour cell proliferation, 
decreased or resistance to apoptosis, angiogenesis, resulting in tumour progression and 
metastasis (Gupta et al., 2015). 
To date, however, none of the biomolecules mentioned above have been established in 
routine clinical trials for oral cancer. There may be a need for studies with greater statistical 
power if any of these biomolecules could serve biomarkers for oral cancer (Gupta et al., 
2016).  
2.6. Management 
The management of potentially malignant oral disorders is not well prescribed. However, 
there is some consensus about the conduct adopted. Reduction of risk factors, complete 
removal of the lesion and monitoring are measures included in this consensus (Jerjes et al., 
2011). 
The reason for the removal of the lesion is to prevent a possible malignant transformation. 
Surgical excision, laser surgery, cryosurgery and photodynamic therapy are some of the 
methods employed for the removal of the lesions. Retinoids also have been speculated as 
an alternative to effective management (Jerjes et al., 2011). 
2.6.1. Surgical Excision (Biopsy) 
Surgical excision is recommended for the presence of epithelial dysplasia (presence of 
moderate and severe epithelial dysplasia). Reports of recurrence rate after surgical 
treatment vary between 10% to 35% (Ribeiro et al., 2010). However, although there is still 
no evidence of success of this therapy, it is an important histological diagnostic tool, and 
therefore it should not be abandoned (Lodi and Porter, 2008). 
Strict monitoring after the intervention should be performed, so that possible recurrences 
can be detected early. In addition, it is imperative to control tobacco and alcohol 
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consumption after the intervention with the intention of preventing possible recurrences 
(Pandey et al., 2001). 
2.6.2. Laser Surgery 
Carbon dioxide (CO2), NdYAG and KTP lasers have been used with various techniques of 
vaporisation or excision for treatment of OL (Ishii et al., 2003).  
Laser excision or ablation using CO2 laser is a treatment performed since the early 1970s. 
This treatment modality consists of the application of the IR laser on the lesion, causing an 
increase of the temperature of the target tissue to 100 ° C, with consequent conversion of 
water to vapour. The destruction of the tissue after the laser surgery is proportional to the 
adjustment of the power and duration of the application (Meltzer, 2007). 
However, when excision is performed by this technique, the cauterisation of the edges of 
the specimen may prevent the evaluation of its involvement in this region in the 
histopathological examination. Regarding ablation, the main criticism is that the tissue is 
vaporised and is not available for histopathological examination. Thus, multiple biopsies 
should be performed prior to excision to determine the histology of the lesion (Meltzer, 
2007). 
Therefore, although this technique is well accepted for the treatment of OL, laser surgery 
should always be preceded by histopathological confirmation of the nature of the lesion, 
since the confirmation of the excised lesion cannot be done if the ablation technique was 
previously employed (Lodi and Porter, 2008). 
2.6.3. Cryosurgery 
Cryosurgery can be defined as a method of injury destruction by rapid freezing and thawing 
in situ (Prasad et al., 2009). 
Application of extremely cold temperature causes cell death and consequently tissue 
necrosis due to cell disruption, dehydration, enzyme inhibition and protein denaturation. 
Subsequently, in frozen sites where necrosis happens it cures without bleeding or scarring 
(Kawczyk-Krupka et al., 2012). 
Direct and indirect effects are involved in the process of cell destruction by cryosurgery. The 
direct effects consist of intracellular and extracellular formation of ice crystals, which in turn 
rupture the cell membranes. On the other hand, indirect effects are responsible for both the 
vascular changes that cause ischemic tissue necrosis and the cell damage by a cytotoxic 
immune mechanism due to the immune response (Rezende et al., 2014). 
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The dysplastic epithelium is more sensitive to damage induced by cryotherapy in the tissue 
because it has wider intercellular spaces that form more extracellular ice crystals during 
therapy, thus increasing the physical breakdown of cell membranes. In addition, 
proliferating cells also appear to exhibit a better response to therapy compared to resting 
cells. This may explain why lesions of leukoplakia with dysplasia require less cryotherapy 
treatment to achieve complete regression compared to lesions of leukoplakia without 
dysplasia (Lin et al., 2011). 
However, a thicker keratin layer on the surface of the OL can act as a barrier against the 
transmission of low temperatures to the injured epithelial cells, thus hindering the treatment 
outcome. In addition, there are sites with a greater need for treatment time due to a higher 
vascularity that also prevents reaching low temperatures, such as tongue (Lin et al., 2011). 
2.6.4. Photodynamic Therapy 
Photodynamic therapy (PDT) is a minimally invasive technique which can successfully 
target pre-malignant and malignant disorders of the head and neck, gastrointestinal tract, 
lungs and skin with great reduction of morbidity and disfigurement (Hopper, 2000; Jerjes et 
al., 2007, Jerjes et al., 2009). 
PDT involves two individually non-toxic components, light and a photosensitiser, that work 
together to induce cell and tissue destruction. This technique is based on the administration 
of photosensitiser to make the tumour tissue responsive to light at a specific wavelength.  
When the photosensitiser is activated in the tissue by a specific light wave, it transfers 
energy from the light to oxygen molecule, resulting in the generation of reactive oxygen 
species (ROS) (Dolmans et al., 2003).  
Therefore, there are three main mechanisms by which PDT can act against tumour cells. 
The first of these is the direct attack of tumour cells by ROS. The second form is damage 
to tumour associated vasculature causing thrombus formation and subsequent tumour 
infarction. The third mechanism is induction of an immune response to tumour cells 
(Dolmans et al., 2003). 
Photofrin (porfimer sodium), 5-ALA (5-aminolaevulinic acid) and verteporfin (BPD, 
benzoporphyrin derivative) have been approved as PDT photosynthesisers by regulatory 
authorities (Hopper, 2000; Jerjes et al., 2007, Jerjes et al., 2009). 
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3. Raman Spectroscopy 
Spectroscopy has emerged as an important tool for biomedical application and it has been 
progressing towards the the clinic. Among the research carried out using the techniques of 
spectroscopy in natural tissues, Raman spectroscopy has been extensively explored 
(Movasaghi et al., 2010). Raman spectroscopy is based on the Raman scattering 
phenomenon, a type of scattering observed in the interaction of light with matter, postulated 
by Smekal in 1923 and observed experimentally for the first time by Raman and his student, 
Krishnan, in 1928 (Singh, 2002).  
Raman spectroscopy is a technique of VS based on the dispersion of light after its 
interaction with a matter. The result of the wavelength shift of the molecule is used to 
determine the vibrational and rotational modes present in the sample. Thereby, Raman 
spectroscopy, is a tool that provides biochemical information as well conformation and 
concentration of the constituents (Keller et al., 2006; Clemens et al., 2014; De Luca et al., 
2015;).  
3.1. Theory 
Raman spectroscopy is an inelastic photon scattering process in which a molecule absorbs 
an incident photon and emits a photon, causing a transition of the molecule from one 
vibrational energy level to another that results in an emitted photon with a different 
frequency of the incident photon (Haka et al., 2005). Raman spectra are chemically specific 
because energy levels are unique to each molecule. Therefore, individual bands in the 
Raman spectrum are characteristic of specific molecular motions (Haka et al., 2005). A 
simple schematic diagram of a typical Raman spectrometer is shown in FIGURE 4, 
illustrating the key elements, and the following section summarises how Raman 
Spectroscopy works.  
Raman spectroscopy is a result of coupling of light with movements (vibrations and 
rotations) on the atomic and molecular scale. The basic principle of Raman spectroscopy 
involves the excitation of molecules by an incident beam of electromagnetic radiation (of a 
given frequency), followed by analysis of the energy released by the sample at all 
frequencies, except for the input beam frequency. Raman spectroscopy, basically, reflects 
the inelastic collision of the electromagnetic radiation with the sample (Magdalena et al., 
2016). 
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Figure 4.  Typical set-up for Raman Spectroscopy (Adapted from Byrne et al., 2011) 
When a photon interacts with a molecule, it can be scattered elastically (Rayleigh scattering) 
and inelastically. The inelastic diffuse part is called the Raman scatter. In inelastic 
scattering, the photons can suffer a loss of energy (Stokes scattering) or a gain of energy 
(anti-Stokes scattering). Among the two forms of scattering, the dominant phenomenon is 
Rayleigh scattering, and only a small amount of light is scattered inelastically (one in 106 
and 108 photons) (Hollas, 2004; Clemens et al., 2014). Due to this low efficiency, Raman 
spectroscopy has only become useful with the combination of high-intensity continuous-
wave lasers and sensitive detectors (Clemens et al., 2014).  
As a result of this energy change of the molecule in the inelastic process, for energy 
conservation, the energy of the scattered photon must be different from that of the incident 
photon by an amount equal to ∆𝐸𝑚according to the following equation (ℎ𝑣𝑖 represents the 
incident photon and ℎ𝑣𝑠 represents the scattered photon) (Colthup et al., 1990): 
ℎ𝑣𝑖 − ℎ𝑣𝑠 = ∆𝐸𝑚 
FIGURE 5 depicts the Stokes and the anti-Stokes scattering processes and their respective 
frequencies. Stokes scattering results in the promotion of the molecule to a higher energy 
vibrational state, while anti-Stokes scattering results in the annihilation of a vibrational 
quantum, as a result of which the molecule is in a lower energy vibrational state. As, at room 
temperature, the number of molecules in the ground state is greater than the number of 
molecules in the excited state, Stokes scattering has a greater probability than anti-Stokes 
scattering (FIGURE 5b). 
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Figure 5.  a) Schematic of the Raman process in different level system b) The resulting Raman 
spectrum (Adapted from Mazzei, 2014). 
Polarisability is the ability of electronic clouds around the molecule to interact with an electric 
field (Clemens et al., 2014). Raman scattering occurs only in molecules capable of 
undergoing a change in polarisability, meaning that there is deformability in the electron 
cloud in a molecule resulting from the interaction of light according to the following equation 
(Colthup et al., 1990; Ferraro et al., 2003): 
𝜕α
𝜕𝑄
 ≠ 0 
where α is molecular polarisability, and Q is the normal coordinate of vibration. 
The nondestructive nature of Raman spectroscopy, especially when the laser is used in the 
therapeutic window (700-1100 nm) and the fact of no need for labelling with extracellular 
agents to increase the contrast are characteristics that confer important advantages to this 
technique (De Luca et al, 2015). 
Raman spectroscopy and IR have some advantages over one another, and hence are 
considered complementary tools for the investigation of atomic and molecular vibrations 
(Magdalena et al, 2016). Generally, molecular vibrations that result in a strong Raman 
signal, produce a weak IR signal and vice versa (Clemens et al., 2014). 
Thus, vibrations of polar bonds and asymmetric molecules tend to absorb strongly for IR 
spectroscopy, whereas these molecules produce poor intensities for Raman spectroscopy, 
and in the case of vibrations of symmetrical and non-polar molecules are more suitable for 
Raman analysis (Clemens et al., 2014). 
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Unlike FTIR, the Raman signal is several orders of magnitude weaker than the intensity of 
the FTIR lines. However, Raman has a distinct advantage of higher spatial resolution and 
additionally it can be employed in the UV, visible and also near IR regions of the 
electromagnetic spectrum, the latter regions being less damaging to tissue, and having a 
longer penetration depth into the sample (up to 1 mm depth). (Krishna et al., 2006; Clemens 
et al. 2014; Singh et al., 2016).   
Moreover, Raman Spectroscopy is significantly less affected by the presence of water and 
CO2, because polar molecules produce relatively weak Raman signals. Therefore, Raman 
is the more suitable analytical method to investigate live cells (Magdalena et al., 2016; 
Clemens et al., 2014).  
As the Raman effect is manifest in scattered light from a sample, Raman spectroscopy, 
therefore, requires little or no sample preparation and is insensitive to aqueous absorption 
bands. In this way, it is possible to measure solids, liquids and gases directly and through 
transparent containers such as glass, quartz and plastic (Ahlawat, 2014). 
3.2. Instrumentation  
For the present study, all Raman spectroscopic measurements were taken using an XploRA 
confocal Raman instrument (HORIBA Jobin Yvon) and its components are schematised in 
FIGURE 6. 
As the Raman effect occurs only with a very small fraction of the incident photons thus, the 
source of the monochromatic incident light used is a laser in which can be different 
wavelengths (from ultraviolet to visible to near infrared) depending on its application 
(Magdalena et al., 2016; Hinrichs and Vasconcellos, 2014). The interference filter has the 
role of "clean up" the output of the laser in order to background removal (Omega Optical, 
2018). 
The coupling of the Raman spectrometer to a microscope objective makes it possible to 
focus on different regions of the sample, as can be seen in the schematic diagram of 
FIGURE 6. The objective lens, therefore, besides delivering the incident laser light, also 
collects and collimates the reflected light by the sample (Rayleigh and Raman scattered 
light) (Byrne et al., 2011).  
Afterwards, the Notch filter removes the strong contributions from the collected light and 
permit the passage of the photons with altered wavelength (Byrne et al., 2011; Hinrichs and 
Vasconcellos, 2014). 
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The diffraction grating, in turn, disperses the transmitted light and allows for low or high 
resolutions measurements determining the spectral resolution. It covers the spectral range 
of interest image normally between 300 mm (medium resolution) to 800 mm (high 
resolution) (Byrne et al., 2011).   
Finally, a charge coupled device (CCD) detectors are usually used to collect the Raman 
signal (Byrne et al., 2011). They also allow multichannel operation, so the complete Raman 
spectrum can be detected in a single acquisition (Byrne et al., 2011, Carron and Besli, 
2015). 
 
Figure 6.  Schematic optical layout of a Raman microspectrometer (Image courtesy Genecy 
Calado). 
3.3. Principal components analysis  
As the differences in Raman spectra associated with biochemical changes in cells or tissue 
can be subtle, sophisticated multivariate statistical techniques are commonly employed to 
highlight them.  
Principal Components Analysis (PCA) is a multivariate statistical technique used to 
systematically reduce the number of dimensions needed to describe some subject in 
question (David and Jacobs, 2014).  
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This technique simplifies the complexity in high-dimensional data while retaining trends and 
patterns and this is performed by transforming the data into fewer dimensions called 
principal components (PCs) which means that each linear combination corresponds to one 
different principal component (PC) (Lever at al., 2017). The main purpose of this is to find 
the best summary of the data using a limited number of PCs (Lever at al., 2017). 
PCA is a powerful tool, when used correctly, that identifies the main axes of variation within 
a data set under analysis allowing an easy data exploration and understanding of key 
variables and outliers (Lever at al., 2017). 
The first principal component (PC1) is a linear combination of the original predictor variables 
which describes the highest amount of variance in the data set. The second principal 
component (PC2) determines the second highest variability in the data set, and so on 
(Bonnier and Byrne, 2012). 
PCA is used to represent the spectra in sets of data of a similar variable, allowing the 
identification and differentiation of different spectral groups. PCA clustering is commonly 
used as, besides analysing large amounts of data, it allows a discrimination of the 
biochemical and differentiation of spectral characteristics which manifest the highest degree 
of variability (Bonnier and Byrne, 2012). A strength of this technique resides in the analysis 
of the loadings, which provide a representation of the spectral origin of the variations that 
differentiate the data groupings according to the wavenumbers (Bonnier and Byrne, 2012). 
4. Use in Oral Cancer 
Chemical and structural changes in the molecular composition in the cell are present at the 
early stages of cancer development. Changes such as increased core-cytoplasm ratio, 
disordered chromatin, increased metabolic activity and changes in lipid, carbohydrate and 
protein levels could, therefore, be used as potential markers for disease monitoring (Keller 
et al., 2006; Mian et al., 2017).  
Raman spectral peaks are particularly prominent in the fingerprint region of around 400–
2000 cm-1, and each peak can be associated with specific vibrations in molecular bonds 
(Keller et al., 2006). 
All these molecular changes can be recorded in Raman spectra and may present as the 
absence or presence of peaks, changes in peak intensities or peak shifts. Since these 
spectral changes are very specific and unique, they can characterise changes to the 
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chemical fingerprint of the cell or tissue under investigation and can be used for early 
diagnosis (De Luca et al, 2015). 
Once dysplasia and micro-invasive carcinoma can be present in clinically normal-appearing 
mucosa, it has been reported many studies in order to detect dysplastic oral mucosa by 
Raman Spectroscopy (Liu et al., 2016; Mian et al., 2017).  
It has been reported that Raman spectroscopy can differentiate normal tissue from 
premalignant and malignant tissue such as in cancers of brain, breast, lower gastrointestinal 
tract, nasopharynx, skin, lung, ovary and cervix (Keller et al., 2006; Guze et al., 2014). 
However, Raman spectroscopy still has limitations for clinical applications due to difficulty 
in capturing intrinsically weak Raman signals and the relatively slow speed of spectral 
acquisition (Guze et al., 2009).  
4.1. Raman spectroscopy of exfoliated cells 
Although the biopsy is the gold standard for screening pre-malignant lesions and diagnosis 
of cancer, it has its limitations such as subjectivity and it is limited to detection of 
morphological changes. Furthermore, since it is an invasive procedure, it causes stress to 
the patients. It is also difficult to determine the most appropriate sampling site, especially in 
the case of large lesions that can have a variety of severity in the same lesion (Poh et al., 
2008).  
In the case as cancers of, for example, the cervix and oral cavity, as dysplastic and 
cancerous cells tend to have fewer and weaker connections to each other and to their 
neighbouring normal cells in the surrounding tissue, brush biopsy could be an alternative 
technique to collect cells from the surface of the lesion (Behl et al., 2017). Exfoliative 
cytology is a less-invasive technique, enable easy sampling and is better accepted by 
patients. However, it still suffers from the same problem of histopathology, subjective 
reading (Behl et al., 2017). 
As the use of Raman spectroscopy for clinical diagnosis by exfoliated cells, has previously 
reported in the case of cervical cancer by Ramos et al. (2016), Raman spectroscopy could 
be used as an auxiliary tool to detect precancerous oral conditions together with exfoliative 
cytology method. This alternative may be rapid, objective, non-invasive new method of 
earlier diagnostic for oral cancer (Behl et al., 2017).  
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III MATERIAL AND METHODS 
1. Cell Samples  
For the analysis of normal cells, oral cytological samples were collected from ten healthy 
donors, and for the analysis of abnormal cells, oral cytological samples were collected from 
ten patients previously diagnosed with oral cancer by histopathological testing, previously 
treated, non-previously treated or already in treatment. The ethical approval was granted 
by the Dublin Institute of Technology Committee on Ethics in Research and from Tallaght 
Hospital Research Ethics Committee with due informed written consent of every one of the 
donors. In addition, this study was conducted in accordance with the ethical principles laid 
down in the Helsinki Declaration (2013).   
The collection of the samples was performed according to protocol proposed by Behl et al. 
(2017), with an appropriate tool to collect the samples, followed by the formation of a 
monolayer sample on a glass slide in order to acquire Raman spectra from the individual 
cells. 
The sites selected for sample collection were two different regions in the oral cavity, in which 
oral cancer commonly develops: the ventral side of the tongue and the buccal mucosa. 
2. Raman Measurements 
Raman spectra were acquired at room temperature (~20ºC) on a XploRA confocal Raman 
instrument (HORIBA Jobin Yvon) equipped with a 532 nm laser giving a power of ~12 mW, 
1200 g mm-1 grating coupled with a thermo-electrically cooled CCD and an Olympus 
100×/NA ¼ 0.9 MPlanN objective. The spectral range was adjusted 400-1800 cm-1 with 30s 
acquisition time per spectrum and averaged over two sample exposures were accumulated.   
On average, 10 to 25 cells were recorded per slide with the aim of calculating the average 
and minimizing the possible heterogeneity present. The acquired spectra were from the 
regions of the nucleus and at random regions of the cytoplasm. 
3. Data Processing 
In order to maintain consistency with the clinical workflow, glass microscope slides were 
used as substrates. To digitally remove the glass contribution to the spectral response, the 
extended multiplicative signal correction (EMSC) (Kerr and Hennelly, 2016) method was 
applied, in which mean spectrum of 10 cells spectra acquired on CaF2 disc is used as used 
reference.  
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The mean of a 300-glass spectral matrix is also used as input for glass reference which 
needs to be removed from the dataset of exfoliating cells. After EMSC correction, spectra 
were subjected to smoothing (Savitzky–Golay method, k = 5; w = 13), baseline correction 
(rubber band) and vector normalisation by Matlab software.   
PCA was used to visualise the systemic variation in the data comprising of nucleus and the 
cytoplasm after correction of spectra with the subtraction of the glass spectrum (ThinPrep 
glass slide).  
4. Fatty Acids 
A spectral library of six different lipids was established: 
1. Cholesterol (CHO); 
2. Sphingomyelin (SM); 
3. L- α- Phosphatidylcholine (PC); 
4. 3- sin- Phosphatidylethanolamine (PE); 
5. 3- sin- Phosphatidyl- L- serine (PS); 
6. Phosphatidylinositol (PI). 
According to the literature, CHO is one of the main lipids involved in carcinogenesis. SM, 
PC, PE, PS, PI are conjugated lipids present mainly in the cell membrane and they also 
have important roles in cellular metabolism. 
The lipids were purchased in powder form and before analysing by Raman Spectroscopy, 
they were prepared in solution dissolved in PBS. They were stored at −20 °C and were used 
without further purification.  
For spectral acquisition by Raman Spectroscopy (Section 3.2), the laser used was of 
wavelength 532 nm of ~12 mW power focused by a 50x (MPlanN, Olympus, NA ¼ 0.9) 
objective onto the lipids, filter 100%, range between 400-3500 cm-1, grating 600 g mm-1, 
with acquisition time of 10s and three accumulations at room temperature (~20ºC). The 
spectra obtained were pre-processed using Matlab software in the same manner as the 
spectra from the sample exfoliated cells discussed above.  
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5. Analyses    
PCA was carried out on spectra obtained from nucleus and cytoplasm in the normal and 
abnormal cells. The wavenumbers of the lipid peaks in the PCA analysis were compared to 
the wavenumbers of the library lipids in order to determine whether any of these lipids 
selected match the profile of lipids observed in the spectral differences between the normal 
and abnormal cells. 
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IV RESULTS AND DISCUSSION  
1. Exfoliative Cells Analysis  
As an illustration of the methodology of multivariate analysis applied to Raman 
spectroscopy, a plot of mean spectra from cytoplasm and nucleus of exfoliated buccal and 
tongue cells is shown in FIGURE 7. The spectra of cytoplasm and nuclei are remarkably 
similar, although there are notable differences between them, which are difficult to visualise 
by eye.     
 
Figure 7.  Mean Raman spectra of nucleus and cytoplasm from exfoliated buccal and tongue cells 
of the healthy volunteers. 
PCA was applied to spectra from tongue cells and buccal cells (FIGURE 8). In the scatter 
plot there is a correlation between the nucleus spectra of tongue cells and the nucleus 
spectra of buccal cells and between the cytoplasm spectra of tongue cells and the 
cytoplasm spectra of buccal cells. Thus, it is possible to cluster cytoplasm spectra and 
nucleus spectra using PC1. 
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Figure 8.  PCA scatter plot of spectra collected from nucleus and cytoplasm of tongue and buccal 
cells from healthy volunteers. The scatter plot shows that PC1 can discriminate nuclear 
spectra from cytoplasm spectra.  
The PCA-loadings represent the variance for each variable (wavenumber) for a particular 
PC as shown in FIGURE 9. The PC loadings provide about the source of the variability 
within a dataset (Bonnier and Byrne, 2012). As expected, the nuclear and cytoplasmic 
regions of the cells are differentiated by the prominence of nucleic acids in the nucleus and 
proteins in the cytoplasm. 
 
Figure 9.  PC1 loading for the scatter plot shown in FIGURE 7 showing prominent DNA peaks for 
the nuclear spectra and prominent protein peaks for the cytoplasm spectra. 
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2. Healthy volunteer samples vs patient samples 
According to Behl et al. (2017) results, comparing the spectra from the normal and abnormal 
exfoliated cells from healthy volunteers and patients, it is possible to notice subtle 
differences in the mean spectra of the cytoplasm (FIGURE 10) and nucleus (FIGURE 11). 
Therefore, it is possible to conclude that there are biochemical changes between both 
samples which may be further examined by multivariate analysis. 
 
Figure 10.  Mean Raman spectra of cytoplasm from exfoliated buccal and tongue cells of the healthy 
volunteers (normal) and patients (lesion).    
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Figure 11.  Mean Raman spectra of nucleus from exfoliated buccal and tongue cells of the healthy 
volunteers (normal) and patients (lesion).    
PCA was applied to spectra of normal and abnormal cytoplasm and normal and abnormal 
nucleus to investigate the variance between normal and abnormal samples. According to 
the PCA scatter plots and loading in FIGURE 12 and FIGURE 13, the difference between 
both samples become much more visually clear because it is possible to see what is varying 
specifically between both samples.  
In the PCA-loading, the peaks present in the positive part are more prominent in the normal 
cells, and the peaks present in the negative part are more prominent in the abnormal 
samples. Thus, these differences could be a potential spectral marker for oral pre-cancer 
and cancer. However, the greatest challenging task is to establish which biomolecules are 
responsible for those changes. 
Spectral assignments can be made according to literature (Movasaghi et al., 2010). For the 
case of the loading of FIGURE 12 and FIGURE 13 the peaks present in the negative part 
are assigned primarily to lipids and the peaks present in the positive part are predominantly 
protein.  
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Figure 12.  PCA scatter plot of spectra collected from cytoplasm of tongue and buccal cells from 
healthy volunteers (normal) and patients (lesion). The scatter plot shows that PC1 can 
discriminate normal spectra from lesion spectra. The PC1 loading shows prominent lipid 
peaks for the lesion spectra and prominent protein peaks for the normal spectra. 
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Figure 13.  PCA scatter plot of spectra collected from nucleus of tongue and buccal cells from healthy 
volunteers (normal) and patients (lesion). The scatter plot shows that PC1 can 
discriminate normal spectra from lesion spectra. The PC1 loading shows prominent lipid 
peaks for the lesion spectra and prominent protein peaks for the normal spectra. 
As was detailed in section 2.5.5., there are already some biomolecules that have been 
studied as biomarkers of oral cancer, such: as miRNA-184, IL-6, Cyclin D1, EGFR, P53 
mutation and so on.  
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However, these biomolecules are predominantly protein, which are not the best candidates 
for spectral markers, as they are structurally similar to the other highly abundant proteins in 
the cell. Thus, the Raman signal could be similar and difficult to distinguish each from them.  
Therefore, lipids may be the best potential spectral marker since they produce significant 
Raman signals and they are present in greater amounts in the abnormal cells, possibly due 
to the carcinogenesis process.  
3. Lipids 
There is a metabolic reprogramming in cancer that causes uncontrolled cell proliferation. 
These phenotypic changes occur because of successive oncogenic events such as 
activation of oncogenes and loss of tumour suppressors (Boroughs and DeBerardinis, 
2015). 
The cancer cells present a metabolism that offers the flexibility to resist and grow in 
restricted conditions (with poor oxygenation and nutritional shortage) (Boroughs and 
DeBerardinis, 2015). The first adaptive events of their metabolism are an exacerbated 
glucose uptake and use of glycolysis leading to increased lactate production (Warburg 
effect) (Boroughs and DeBerardinis, 2015). Cancer cells also depend on glutamine 
consumption, which provides carbon and amino nitrogen necessary for biosynthesis of 
amino acids, nucleotides and lipids (Beloribi-Djefaflia et al., 2016). 
Lipids are dependent on the catabolic pathways of glucose and glutamine, and thus there 
are changes in lipids and cholesterol-associated pathways in tumours (Beloribi-Djefaflia et 
al., 2016). 
Lipids are known to be important in several biochemical functions during carcinogenesis, 
although, it is still not well known about the functional alteration of lipids and their diversity 
(Beloribi-Djefaflia et al., 2016).  
Malignant cells appear to have an avidity for lipids and CHO either by increasing their 
absorption of exogenous lipids and lipoprotein or by an over-activity of their endogenous 
synthesis (Beloribi-Djefaflia et al., 2016). 
Over time, lipids have been considered only as passive components of cell membranes, 
where they form lipid rafts that facilitate signalling of protein recruitment and therefore 
protein-protein interactions that promote signal transduction. However, a more complete 
understanding of the complexity of their structural roles is emerging.  
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Lipids are involved in significant functions, such as signal transduction cascades and 
bioactive lipid mediators, which are responsible for the regulation of several essential 
functions in cancer, such as cell growth, cell migration and metastasis formation (Beloribi-
Djefaflia et al., 2016). 
Lipids comprise biomolecules with different chemical structure regarding length, number 
and location of double bonds, also backbone structures such as glycerol and sphingoid 
bases (Loizides-Mangold, 2013). Although the function of each variety is not yet well 
understood, it is known that lipids play an important biochemical role in the development of 
cancer (Loizides-Mangold, 2013). 
3.1. Lipids in the Cells 
Lipids are a complex molecular class with vast structural diversity, originating mainly from 
several combinations of fatty acid chain lengths and possible major groups that are linked 
to a glycerol backbone. (Yetukuri et al., 2008). Although lipids are made up of a limited 
number of building blocks, they have the potential to generate a wide diversity of molecular 
species, which may contain phosphoric acids, organic bases and also carbohydrates 
(Loizides-Mangold, 2013).   
Lipids, besides being components of great importance in the constitution of cell membranes 
and having the function of energetic resources, they also play a crucial role both in 
homeostasis and cellular physiology (Hu et al., 2013).  
The most common lipid classes that play roles in membrane structure and energy storage 
in cells are mainly glycerophospholipids, sphingolipids, sterols and triglycerides (TAGs) in 
which the glycerophospholipids, sphingolipids and sterols are present mostly in the 
membrane (Loizides-Mangold, 2013).   
Glycerophospholipids and triglycerides are fatty acids (FAs) linked by ester bonds to 
glycerol, whereas sphingolipids are sphingoid bases linked by amide bonds to FAs 
(Loizides-Mangold, 2013).   
Glycerophospholipids are classified according to their headgroup: PC, PE, PI, PS, 
phosphatidylglycerol (PG) and phosphatidic acid (PA) (Loizides-Mangold, 2013). 
Sphingolipid, in its turns, is also classified by their head groups such with a hydroxyl group 
found in ceramides, phosphorylcholine in SM, and carbohydrates in the various 
glycosphingolipids (Reynolds el at., 2003). 
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These phospholipids are fundamental for cellular membrane remodelling and cellular 
proliferation (Reynolds el at., 2003; Hu et al., 2013).  
Phospholipid synthesizing enzymes can be found in several cell compartments, mainly in 
the endoplasmic reticulum and in the mitochondria, although some PC biosynthesis occurs 
in the nucleus (Loizides-Mangold, 2013). 
Recent growing interest in lipid research is an indication of their critical biological 
importance. Currently, there is a field called "lipidomics" whose main objective is to 
characterise the lipid molecular species and their biological roles regarding the protein 
expression in lipid metabolism, including gene regulation (Yetukuri et al., 2008). 
3.2. Fatty Acids 
The degree of saturation or unsaturation, the chain length, the spatial configuration (cis / 
trans) of the double bonds and odd number of carbon atoms are important for the function 
of FAs (Najbjerg et al., 2011, Czamara et al., 2015). They are classified in two different 
groups: saturated and unsaturated according to the absence or presence of double bonds 
respectively. Unsaturated FAs can be monounsaturated (MUFAs) or polyunsaturated 
(PUFAs) according to scheme below (FIGURE 14) (Czamara et al., 2015): 
 
Figure 14.  Chemical structure of some FA: saturated (a) and unsaturated (b) as examples (Adapted 
from Czamara et al., 2015). 
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Lipids can be free or bounded to proteins, carbohydrates and other lipids. Such links may 
be Van der Waals interactions (usually lipid-lipid); electrostatic and hydrogen binding (lipids 
and proteins) or covalent bonds (lipids, carbohydrates and proteins) (AAFCO, 2014). 
Lipids are generally non-polar compounds (Van der Waals interaction), therefore they are 
soluble in non-polar solvents. Thus, lipids such as triglycerides or CHO esters are not 
soluble in water and in polar solvents such as methanol but are soluble mainly in non-polar 
organic solvents such as hexane, toluene or cyclohexane and also in some moderately 
polar solvents (Christie, 1993; Bailwad et al., 2014). 
However, there are lipids considered polar because they contain in their chain polar groups 
such as phospholipids and glycosphingolipids, which are therefore only slightly soluble in 
hydrocarbons but readily dissolve in polar solvents such as methanol, ethanol or chloroform 
(Christie, 1993). 
The level of lipid solubility in alcohols can be explained by the fact that the longer the chain 
length of the hydrocarbon of alcohol is, the more non-polar it is. Thus, hence the lipids are 
more soluble in alcohols with longer chain length, so lipids are more soluble in butanol than 
in ethanol for example (Christie, 1993). 
3.3. Fatty Acids in Oral Mucosa 
The buccal mucosa consists of lamina propria covered by a stratified squamous epithelium. 
The epithelium keratinized is present in the hard palate and gingiva and in the keratinized 
region there is a stratum corneum (avascular viable epidermis) as in the skin. In the 
epithelium nonkeratinized is present in the buccal region, in the floor of the mouth and in 
the lower part of the tongue (Dawson et al. 2013).  
The region of the tongue dorsum consists of a specialised epithelium (mosaic between a 
keratinised epithelium and non-keratinised epithelium) (Dawson et al. 2013). 
Lipids in the outer portion of the oral epithelium are responsible for the permeability barrier, 
provide an antimicrobial barrier on the epithelial surfaces and has a strong immunologic 
role. In the following table important lipids present in each region of the oral cavity are listed 
(TABLE 2) (Brogden et al., 2012). 
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Table 2. Descriptions of some lipids present in the oral cells (Adapted from Dawson et al. 2013). 
Lip Triglycerides (Lauric acid, Sapienic acid); CHO esters; CHO 
Keratinized oral 
epithelium 
Ceramides; CHO; Phospholipids; 
Glucosylceramides 
Nonkeratinized 
epithelium 
Ceramides; CHO; Phospholipids 
3.4. Lipidomics and Cellular Pathologies 
Abnormal lipid metabolism is related to pathogenesis of several diseases as steatohepatitis, 
insulin-resistant diabetes, Alzheimer's disease, inflammation, atherosclerosis, obesity, in 
addition to coronary heart disease and different cancers, such as breast and colorectal 
(Yetukuri et al., 2008; Loizides-Mangold, 2013; Kumar et al., 2012). 
Disruption of phospholipid homeostasis may lead to carcinogenesis and metabolic 
syndrome (MS). Triacylglycerol, for exempla, is related to glucose homeostasis and its 
dysregulation is associated with MS such as diabetes, obesity, and cardiovascular disease 
(Hu et al., 2013). 
Tumour cells often require basic biochemical components well above normal limits used in 
the physiological process. One of these components are the lipids that form the major 
components of the cell membrane and are essential for biological functions such as cell 
division and cellular proliferation (Kumar et al., 2012). 
During metastasis, the stem cells are guided by metastasis-inducing molecules. In this way, 
these cells can cross the endothelial barrier and reach the bloodstream until they cross the 
capillary endothelium again and reach a target organ (Fernandis and Wenk, 2009). 
In this new site, these cells lodge in the basal lamina, proliferating, thus causing the 
formation of a new tumour. Thus, the barrier of the cells involved is closely related to 
carcinogenesis (Fernandis and Wenk, 2009). 
The lipids and proteins make up 50% of the cellular bio membrane. They are mainly sterols 
(mainly CHO), glycerol-based phospholipids like PC, PI, PS and ceramide sphingolipids 
(Fernandis and Wenk, 2009). 
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They, therefore, are closely related to the carcinogenesis process once lipid-lipid and lipid-
protein interactions are important for the membrane flow, the nonlamellar phase of 
microdomain formation, the endocytosis, the control of antigen presentation, and also the 
construction of bio membranes of new cells during cell replication (Fernandis and Wenk, 
2009). 
Moreover, lipids are involved in other important and vital functions in the cells as source of 
energy, regulation of several signalling molecules (phosphoinositide and ceramide), 
precursors for second messengers such inositol trisphosphates (IP3)/DAG in which are 
responsible for cell proliferation, inflammation, immunity, apoptosis, replication etc 
(FIGURE 15) (Fernandis and Wenk, 2009). 
 
 
 
Figure 15.  Lipids and their relation to cancer (Adapted from Fernandis and Wenk, 2009). 
It has been reported that there is an overexpression of fatty acid synthase in the cancer cell 
suggesting that these lipids have an important role in tumorigenesis and de novo 
synthesised FAs are required for the rapid proliferation of cancer cells (Kim et al., 2016). 
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3.5. Lipids as a Biomarker  
Although the role of lipids was previously only seen as part of membrane structure and 
energy storage, it is already established that there are important functions in cells in which 
lipids participate, such as regulatory and signalling molecules (Loizides-Mangold, 2013). 
Raman spectroscopy is a promising technique for the intracellular analysis of lipid species, 
because lipid species are polarisable, giving rise to strong signals in Raman spectra 
(Jamieson et al., 2018). Therefore, lipids may be a potential spectral marker for the 
diagnosis of pathologies in the cells.     
4. Library of Lipids  
The spectra of these six different selected lipids were recorded to compare to PCA carried 
out on spectra from healthy volunteer (normal) and patient (lesion) samples. The spectra 
are shown in FIGURE 16. 
 
Figure 16.  Spectra collected from the six selected lipids: CHO, PE, PI, PC, PS and SM by Raman 
Spectroscopy. 
5. Raman Spectral Analysis 
A comparison of the differentiating PC loading (from cytoplasm and nucleus spectra shown 
in FIGURE 12 and FIGURE 13) and lipid spectra is shown in FIGURE 17 and FIGURE 18.   
51 
 
 
 
52 
Figure 17.  Cytoplasm PC1-loading (from FIGURE 11) compared to all six lipids spectra (SM, PS, 
PC, PI, PE CHO). The bands in blue correspond to the PC1-loading from the cytoplasm 
and the lipid spectra are in red. 
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Figure 18.  Nucleus PC1-loading (from FIGURE 12) compared to all six lipid spectra (SM, PS, PC, 
PI, PE, CHO). The bands in blue correspond to PC1-loading from the nucleus and the 
lipid spectra are in red. 
 
6. Data Analysis: Interpreting Spectroscopic Data 
Interpreting the results above, not only the wavenumber present in the lipid loading but also 
the lipid wavenumber assignments from the literature was considered (Movasaghi et al., 
2010). Since the lipids were hydrated and the cells were dehydrated in their preparation, 
the wavenumber present in the plots may not be a very accurate match.   
Nevertheless, according to the results it is possible to conclude that SM and PS could be 
potential lipid contributors in the lipids changing between the samples, because they are 
present in greater amount in the abnormal cytoplasm as well in the abnormal nucleus. The 
plots below show which bands were considered (FIGURE 19 and FIGURE 20).  
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Figure 19.  Marked bands in common between PS and SM lipids and cytoplasm PC1-loading. 
 
 
Figure 20.  Marked bands in common between PS and SM lipids and nucleus PC1-loading. 
In healthy eukaryotic cells, PS is an essential component and is present predominantly in 
the inner leaflet of the cellular membrane (Zhang et al., 2014; Leite et al., 2015; 
Vallabhapurapu et al., 2015; Sharma and Kanwar, 2017; Wang et al., 2017).  When the PS 
is in the inner membrane, it has specific functions such as important roles in the activation 
of key kinases like protein kinase C (PKC),  
Phosphoinositide-dependent kinase-1(PDK1), and Protein kinase B (PKB) and are an 
essential molecule for several signalling proteins (Vallabhapurapu et al., 2015). However, 
the PS distribution in the cell membrane can undergo alterations according to the different 
stimuli inside and outside of the environment causing the externalisation of the PS on the 
membrane.  
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It may be caused by Ca2+ influx, low flippase activity (aminophospholipid translocases), 
oxidative stress, cytokines, activation of the complement cascade, CT, RT and among 
others (Vallabhapurapu et al., 2015; Sharma and Kanwar, 2017). 
PS is a phospholipid mainly related to the immune response, in this way, in certain situations 
it is externalised on the cell membranes (Birde et al., 2016; Sharma and Kanwar, 2017). It 
is, therefore involved in processes related to immunological activation, such as apoptosis, 
autoimmune diseases, and inflammatory responses present for example in a process of 
carcinogenesis (Birde et al., 2016). A schematic (FIGURE 21) shows what happens on the 
outer leaflet of the membrane in the tumour cells. 
 
Figure 21.  Schematic mechanisms for PS asymmetry in normal cell membrane and its loss in tumour 
cells. PS = phosphatidylserine (Adapted from Wang et al., 2017). 
Once PS is externalised, it is recognised by macrophages and phagocytes that have 
specific receptors for PS, the "eat me" signal, and therefore, these cells are phagocytosed 
by the macrophages concluding the process of self-destruction, apoptosis (Wang et al., 
2017). Hence, PS is present in large amounts in autoimmune diseases, for example (Birde 
et al., 2016). 
However, this is not observed in the process of tumorigenesis. Although PS does indeed 
occur on the outer membrane leaflet as a defence response of the organism, cells are not 
phagocytosed by phagocytes as expected, because in the carcinogenic process there is an 
overexpression of CD47 in the surface cell of the macrophage which inhibits the phagocytic 
cells to comply with their role (Rivera et al., 2015; Zhao et al., 2016; Sharma and Kanwar, 
2017). 
CD47 is a membrane protein that interacts with the SIRPα receptor expressed in phagocytic 
cells such as macrophages. This binding results in the inhibition of macrophage-mediated 
also called the "don’t eat me" signal (Rivera et al., 2015; Zhao et al., 2016; Sharma and 
Kanwar, 2017). 
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The reason for over-expression of CD47 during this carcinogenesis process is not yet well 
understood (Zhao et al., 2016). However, its presence has been reported in many cancers 
and also related to invasion of tumours and metastasis such as in myeloid leukaemia, 
lymphoma, multiple myeloma, melanoma, hepatocellular carcinoma and breast, prostate 
and colon cancer being a potential biomarker of therapeutic target (Rivera et al., 2015; Zhao 
et al., 2016; Sharma and Kanwar, 2017). 
Therefore, several studies have reported PS as a possible biomarker for cancer and have 
already been used in the case of pancreatic cancer, glioblastoma and lung cancer cells 
treatment by PS targeted nanovesicles (Sharma and Kanwar, 2017). 
Thus, Raman Spectroscopy has been shown here to corroborate the presence of PS in the 
patient samples. Therefore, in addition to PS being a possible biomarker for oral cancer, it 
also could be a possible spectral marker. 
SM, is a phospholipid of the class of sphingolipids that besides participating in the cellular 
membrane, plays a fundamental role in several metabolic processes in the cells (Ryland et 
al., 2011; Kozar et al., 2018). It is known that during carcinogenesis there is a disequilibrium 
in sphingolipid metabolism although the reason for these changes is not very well 
understood (Modrak et al., 2006; Ryland et al., 2011; Beckham et al., 2013). 
Sphingolipids are made up mainly of ceramide, SM, sphingosine, sphingosine-1-phosphate 
(S1P), ceramide-1-phosphate (C1P) etc. and are present in different cellular compartments 
(nuclei, plasma membrane and different organelles such as mitochondria, endoplasmic 
reticulum and Golgi) (Modrak et al., 2006; Hait and Mait, 2017; Ogretmen, 2018). 
Ceramide is involved in the process of cell death, such as apoptosis, cell growth inhibition, 
autophagy, necrosis and also inflammatory signalling (Ryland et al., 2011; Ogretmen, 
2018). Moreover, its production is increased during situations of cellular stress, such as 
oxidative stress often caused by especially inflammatory process, RT, QT etc (Ogretmen, 
2018). In contrast, S1P is responsible for maintaining survival and growth cellular (Ryland 
et al., 2011). Thus, in a healthy cell, it is fundamental that there is a balance between these 
two components (Oskouian and Saba, 2010).  
Ceramide generation can occur by different known pathways: synthesis of SM catabolism 
mediates by SMase, from activation of de novo by catabolism of glycosphingolipids or 
dephosphorylation of metabolites like ceramide 1-phosphate and 1-O-Acylceramides 
(Oskouian and Saba, 2010; Separovic et al., 2017; Ogretmen, 2018). 
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Once ceramide is produced, it may accumulate in the cell or may be converted to other 
components. Its catabolism can result in biosynthesis of SM, S1P through sphingosine 
formation, glucosyl-ceramide (GC), among other metabolites (Reynolds et al., 2004; 
Oskouian and Saba, 2011). These processes are shown in FIGURE 22. 
SM, therefore, can be generated from the catabolism of ceramide by the action of the 
enzyme SM synthase (SMSs), and its degradation occurs via sphingomyelinase (SMase) 
producing ceramide again (Reynolds et al., 2003; Hait and Mait, 2017; Kozar et al., 2018). 
The imbalances, thus, between both occur basically by an imbalance of the action of SMSs 
and SMases (Kozar et al., 2018). 
 
Figure 22.  Ceramide may be generated via sphingomyelinase (SMase) and via the de novo 
sphingolipid biosynthesis pathway from condensation of palmitoyl-CoA and serine. On 
the other hand, ceramide may generate glucosylceramides by via glucoyl-ceramide 
synthesis (GCS), sphingomyelin (SM) by via sphingomyelin synthase (SMSs), 
sphingosine-1-phosphate (S1P) by via sphingosine-1-phosphate synthesis (S1PS), 1-O-
Acylceramides by 1-acil ceramidase synthase and so on (Adapted from Reynolds et al., 
2003).    
In the carcinogenic process, an increase in the generation of ceramide due to cellular stress 
is observed, which corresponds to an attempt to combat the progression of cancer. 
However, sphingolipid metabolism dysregulation is also present, and overproduction of SP1 
is observed, which contributes to tumour progression (Oskouian and Saba, 2010; Ryland 
et al., 2011) 
In this way, metabolic conversion of ceramide to S1P, SM or glucosylceramide is 
established to play a crucial role in the anti-apoptotic and pro-survival roles, and therefore, 
in the progression of tumours (Oskouian and Saba, 2011; Hait and Mait, 2017; Ogretmen, 
2018). 
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Therefore, exogenous ceramide has been explored to treat cancer and the results have 
been promising, but with limitations as yet (Ryland et al., 2011; Ogretmen, 2018). Another 
possible alternative would be to use SP1 as a target, preventing its action (Ryland et al., 
2011; Ogretmen, 2018). 
In several different studies, both the increase of ceramide and its decrease in different types 
of tumour have been observed. For example, ovarian tumours, high-grade brain tumours, 
and astrocytomas have been related to high levels of ceramide, whereas in colon cancer 
tissue ceramide as well sphingomyelin show ceramide decreases. In contrast, head and 
neck cancer have been reported to result in an increase of C18-ceramide and decrease of 
C16-, C24- and C24:1, and in colorectal cancer increases of C14, C16, C24:1 and 26:1 and 
decrease of C18–C24 are reported (Ryland et al., 2011; Kozar et al., 2018). Therefore, it is 
a complex process to understand (Ryland et al., 2011).   
It appears logical that, especially in response of RT and CT stress, the level of ceramide 
increases, and the main route to generate ceramide is through hydrolysis of SM (Modrak et 
al., 2006). Therefore, SMase is observed in high levels in some studies after these 
treatments, indicating overproduction of ceramide as has been detected in leukaemia 
treatment (Beckham et al., 2013). 
However, a decrease of ceramide occurs after patients have been undergone cancer 
treatments (Beckham et al., 2013). So, the ceramide accumulation is degraded by one of 
the pathways responsible for it, especially by GCS, ceramidases, sphingosine kinases and 
activation of sphingomyelin synthase have been observed (Modrak et al., 2006; Beckham 
et al., 2013; Ogretmen, 2018). Thus, some of these pathways have been studied as possible 
therapeutic targets (Ryland et al., 2011).   
In this way, the increase in the level of cellular ceramide can be explained by the 
carcinogenesis process and also due to the cellular stress caused by the RT and QT 
treatments, that occurs especially through the catabolism of SM by activated SMase 
pathway (Modrak et al., 2006; Ryland et al., 2011; Beckham et al., 2013; Ogretmen, 2018). 
Its decrease, on the other hand, may be related to a poor prognosis and/or a result of 
resistance to treatments as well as high level of S1P (Ryland et al., 2011; Beckham et al., 
2013) 
Therefore, SM present in high level in the samples, in fact, is definitely related to the 
metabolic processes involved in cancer. However, it is not possible to confirm that the 
presence of SM indicated in the samples could be a spectral marker for oral cancer. 
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Since the samples collected were from cancer patients who have already been treated or 
not, the results could be related only as a response to oncological treatments. Given this, it 
is suggested that a more restricted collection of samples be performed with the requirement 
only of patients who have never been previously treated for cancer. In this way, it would be 
possible to determine with more accuracy whether SM is changing in the pre-malignant or 
malignant oral cells due to the carcinogenesis process itself.  
CHO is an important lipid present in the human body with storage function and participating 
in cell structure, cell division, signalling etc., as well as having an important role in vital 
physiological functions such as stabilisation of the DNA helix (Dave et al., 2011; Kumar et 
al., 2012; Singh et al., 2013; Bailwad et al., 2014; Kuzu et al., 2016). Its increase is closely 
related to an increased risk of atherosclerosis, coronary heart disease and is involved in the 
carcinogenesis process, although the mechanism is not well understood yet (Dave et al., 
2011; Kumar et al., 2012; Singh et al., 2013; Bailwad et al., 2014; Mehta et al., 2014). 
It is present in the bloodstream and is transported to the cells and the liver by lipoproteins 
such as chylomicrons, very low-density lipoprotein (VLDL), low density lipoprotein (LDL) 
and high-density lipoprotein (HDL) (Dave et al., 2011; Kumar et al., 2012).  
LDL is the main blood CHO transporter (75% plasma CHO) in the body and together with 
VLDL carries CHO for use of the CHO in tissues, chylomicrons are responsible for the 
transport of CHO in the gut, and lastly, HDL is responsible for the transport of CHO to be 
metabolised in the liver (Dave et al., 2011, Kumar et al., 2012). The cells, in its turn, have 
specific receptors on their surface that uptake CHO for various functions as they need them 
(Patel et al., 2004; Dave et al., 2011; Singh et al., 2013; Bailwad et al., 2014). 
Although CHO is one of the lipids most reported to be substantially involved in the 
carcinogenic process, it was not observed to be increased in the lesion samples collected 
from patients. 
The ThinPrep® method was used for the cell preparation in this study according to the Behl 
et al. (2017) protocol. This method uses methanol-based PreservCyt for fixation and the 
methanol could have influenced the CHO present. However, as already mentioned in 
section 3.1.1. (Fatty Acids), methanol is not considered a good solvent to dissolve CHO 
because it is a non-polar solvent. In addition, membrane lipids that are supposed to be more 
soluble in methanol were indicated in the result. 
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Lately, there have been some discussions about the increase or decrease CHO in cancer 
cells. Some studies have reported that, at the beginning of the carcinogenesis process, 
CHO may be increased or unchanged in the serum, and in contrast, during the carcinogenic 
process there may be decreased CHO (Llaverias et al. 2011; Reddy et al., 2016). 
Recent studies have shown decreased serum total CHO levels in some cancers such as 
carcinoma of breast, cervix, oesophagus, colon, stomach and leukaemia (Dave et al., 
2011), including head and neck cancer (Patel et al., 2004; Lohe et al., 2009; Mehrotra et 
al., 2009; Mehta et al., 2014; Bailwad et al., 2014).  
According to Patel et al., (2004), Lohe et al., (2009), Kumar et al., (2012), Singh et al. (2013), 
Bailwad et al. (2014), Mehta et al. (2014), Poorey and Thakur (2016), Chawda et al. (2011), 
there is an inverse relationship between the level of serum CHO and the presence of 
malignant cells in head and neck cancer. Some studies also indicate decreased serum CHO 
also in premalignant oral lesions (Patel et al., 2004; Lohe et al., 2009; Mehrotra et al., 2009; 
Mehta et al., 2014). However, others have not observed this change (Kumar et al., 2012). 
Given this, there are two hypotheses to explain the CHO decrease in those studies. The 
first explanation could be that changing the amount of CHO would be a predisposing factor 
to the carcinogenic process, due to a deregulation of lipid metabolism, just as other lipids 
are also altered, or a secondary effect on antioxidant vitamins (Patel et al., 2004; Lohe et 
al., 2009; Dave et al., 2011; Singh et al., 2013; Bailwad et al., 2014; Kuzu et al., 2016). In 
this case decreased CHO could indicate an early change of metabolism associated with the 
carcinogenesis process. Another explanation could be that the CHO decrease is a 
consequence of the progression of the carcinogenic process, resulting in a greater demand 
for CHO for the cells to multiply and form new cell membranes due to the accelerated 
mitosis process (Dave et al., 2011; Kumar et al., 2012; Singh et al., 2013; Bailwad et al., 
2014).  
Therefore, decrease in CHO has been speculated as a potential biomarker for early 
diagnosis and prognosis of cancer. However, it is not yet known whether this change occurs 
early or late in the carcinogenic condition (Dave et al., 2011; Bailwad et al., 2014; Anand et 
al., 2018). Hence, these questions remain to be investigated (Patel et al., 2004). 
The results obtained, therefore, corroborates in part those investigations in progress, since 
CHO was not found to be increased in the lesion samples from patients. However, additional 
studies are needed because this subject is still controversial.  
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V CONCLUSION 
Overall, these results show that Raman spectroscopy is sensitive enough to discriminate 
each lipid in the study. Thereby, in fact, lipids could be a possible spectral marker in the 
future and Raman spectroscopy could be helpful to identify these spectral markers.   
This project suggests the importance of studying lipidic changes between normal and oral 
cancer cells. Centrally, this method could test other important lipids in cell metabolism using 
the same protocol. After all, it was proved that there are changes in lipids between healthy 
and cancer oral cells by PCA.   
Regarding the results, first of all, it is not possible as yet to confirm whether SM could be a 
potential spectral marker. Therefore, for future sample collection, it is suggested to select 
only patients that have never previously undergone any treatment.  
PS seems to be a real contributing lipid for the carcinogenesis and also a potential spectral 
marker in the early diagnosis of oral cancer. 
Regarding CHO, as it has been studied as a potential biomarker already, it could be also 
studied further as a spectral marker. However, more in depth studies regarding the 
changing CHO mechanism in cancer is needed. As there is no increase in CHO in the 
results, it is not possible to conclude that there is a decreased CHO. However, the 
observations corroborate some reported studies that there is no increase in CHO during the 
carcinogenesis process. 
To conclude, this study is useful not only to detect changes in lipids but also to allow the 
identification of other components that could be responsible for significant biomolecular 
changes in the metabolism of oral pre-cancer and cancer. 
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